Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
Clinical trial NCT05491083 · RECRUITING
Trial details
- NCT number
- NCT05491083
- Sponsor
- National University Hospital, Singapore
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-12
- Primary completion
- 2026-12-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.